# Warby Parker Inc. (WRBY) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $24.35, market value $3.0 billion.

## Valuation
- **P/E (trailing): 405.8×** (5-yr avg 2179.0×, 3-yr avg 2179.0×). Warby Parker Inc. trades at 405.8× trailing earnings, well below its own five-year average of 2179.0×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 39.6×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.37**. A PEG of 0.37 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 3.3×**. Each dollar of revenue is priced at 3.3×.
- **Price / book: 8.0×**. The shares trade at 8.0× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 0.7%** (5-yr avg -0.5%). Free cash flow equals 0.7% of the market value, above its five-year average of -0.5%, so the shares are cheaper on cash than they have usually been.
- **Earnings yield: 0.2%**. The inverse of the P/E: 0.2% of the price is earned each year.

## Profitability
- **Gross margin: 54.7%**. Warby Parker Inc. keeps 54.7% of revenue after the direct cost of what it sells.
- **Operating margin: 0.2%**. 0.2% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 0.2%**. 0.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 0.4%**. 0.4% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on assets: 1.1%**. Each dollar of assets produces 1.1% of profit.

## Growth
- **Revenue growth (1 yr): 13.0%** (3-yr 13.4%/yr, 5-yr 17.2%/yr). Revenue grew 13.0% over the last year, against 17.2% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 105.9%**. Earnings per share rose 105.9%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 2.35** (quick 2.35). Current assets cover the next year's liabilities 2.35 times.
- **Altman Z-score: 7.35**. A Z-score of 7.35 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Warby Parker Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (13 analysts). 13 analysts cover Warby Parker Inc.; the consensus is buy, with an average price target of $30.46 (+25% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -3.9%** (YTD 11.7%, 3-mo 7.2%). The shares are down 3.9% over twelve months including dividends.
- **From 52-week high: -21.5%** (62.8% above the low). Trading 21% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 42**. An RSI of 42 is neutral.
- **Beta (1 yr): 2.14** (volatility 75%). Beta of 2.14 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=WRBY · Page: https://foliofundamentals.com/stocks/wrby

Not investment advice.